Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotype.

M Falcone,G Tiseo, F Iraci,G Raponi,P Goldoni, D Delle Rose, I Santino,P Carfagna, R Murri,M Fantoni,C Fontana,M Sanguinetti,A Farcomeni,G Antonelli,A Aceti, C Mastroianni,M Andreoni,R Cauda,N Petrosillo,M Venditti

Clinical Microbiology and Infection（2019）

引用 17|浏览0

暂无评分

摘要

Compared to vancomycin, metronidazole monotherapy appears less effective in curing CDI without relapse 027+ patient group, independently from disease severity.

查看译文

关键词

Clostridium difficile infection,Metronidazole monotherapy,Recurrence,Ribotype 027,Severe Clostridium difficile infection

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要